Home > Medical Reference > Encyclopedia (English)

Toggle: English / Spanish

Hypothyroidism - secondary

Alternative Names:

Pituitary hypothyroidism

Treatment:

The purpose of treatment is to replace the deficient thyroid hormone. Levothyroxine is the most commonly used medication. The lowest effective dose that leads to normal thyroid function is used. Life-long therapy may be necessary. Medication must be continued even when symptoms disappear.

After replacement therapy has begun, report any symptoms of increased thyroid activity (hyperthyroidism), such as restlessness , rapid weight loss, and sweating.

A high-fiber , low-calorie diet and moderate activity will help relieve constipation and promote weight loss, if weight was gained during the time when thyroid activity was low.

In individuals with accompanying hypoadrenalism (underactive adrenal gland), steroid replacement must be started before thyroid replacement is begun.

In patients who have hypothyroidism caused by a pituitary tumor, surgery may be required. However, surgery may not cure the hypothyroidism, and thyroid replacement will still be needed.

Myxedema coma is treated by intravenous (IV) thyroid replacement and steroid therapy. Supportive therapy of oxygen, assisted ventilation, fluid replacement, and intensive care nursing may be indicated.

Expectations (prognosis):

With early treatment, return to the normal state is usual. However, relapses will occur if the medication is not continued. Myxedema coma can result in death.

Complications:

Myxedema coma, the most severe form of hypothyroidism, is rare. It may be brought on by an infection, illness, exposure to cold, or certain medications.

Symptoms and signs of myxedema coma include:

Other complications of hypothyroidism include:

Calling your health care provider:

Call your health care provider if signs of hypothyroidism are present, or if chest pain or rapid heartbeat occur.

Call your provider if restlessness, rapid weight loss, sweating, or other symptoms occur after beginning treatment for this disorder.

Call your provider if headache, visual loss, or breast discharge occur.

References:

AACE Thyroid Task Force. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Evaluation and Treatment Of Hyperthyroidism and Hypothyroidism. Endocr Pract . 2002;8 (6).

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process . A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 1997-2007 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

adam.com